[Nle3,d-Phe6 ]-γ2 -melanocyte-stimulating hormone possesses the renal excretory but not the cardiovascular actions of the native γ2 -melanocyte-stimulating hormone in anaesthetized rats.
Cope. Georgina G; Flanagan. Evelyn T ET; Houghton. Belinda L BL; Walsh. Sarah A SA; Johns. Edward J EJ; Healy. Vincent V
Key Findings
- Melanotan‑I (NDP‑γ2‑MSH) caused strong natriuretic (salt‑losing) and diuretic (water‑losing) responses in rats without increasing blood pressure.
- The effect was amplified (2‑7× greater) in rats fed a high‑salt diet and was independent of renal nerve input.
- High‑salt diet rats showed a 4.5‑fold rise in MC3 receptor expression in kidney collecting‑duct cells, suggesting a direct receptor‑mediated mechanism.
Practical Outcomes
- For biohackers, melanotan‑I might offer a way to increase salt and water excretion without the usual rise in blood pressure, which could be useful for short‑term fluid‑weight management. However, the data are from anesthetized rats, so human safety, effective dosing, and long‑term effects are still unknown and require careful clinical testing before any real‑world use.
Summary
In rats, the synthetic peptide melanotan‑I (NDP‑γ2‑MSH) makes the kidneys dump a lot more salt and water, especially when the animal eats a high‑salt diet, but it does not raise blood pressure like the natural hormone does. This kidney effect works even if the kidney nerves are cut and seems to involve MC3 receptors in kidney cells.
Abstract
The present study compared the cardiovascular and renal actions of γ(2) -melanocyte-stimulating hormone (γ(2) MSH) with those of the synthetic analogue [Nle(3) ,d-Phe(6) ]-γ(2) MSH (NDP-γ(2) MSH) and explored the effects of high dietary salt intake on the renal actions of NDP-γ(2) MSH. Both peptides were infused systemically (3-1000 nmol/kg) and intrarenally (500 fmol/min) into innervated and renally denervated rats fed either a normal (0.4% NaCl) or high-salt (4% NaCl; HS) diet. Mean arterial pressure (MAP), glomerular filtration rate (GFR), urinary sodium excretion (U(N) (a) V), urinary output (UV) and fractional sodium excretion were determined, as was expression of the melanocortin MC(3) receptor in inner medullary collecting duct (IMCD) epithelial cells. Both renal and systemic infusion of γ(2) MSH increased MAP by 23 ± 2% and 54 ± 4%, respectively, but equivalent doses of NDP-γ(2) MSH had no significant pressor effects. Both peptides had similar natriuretic and diuretic effects in rats fed a normal salt diet. However, NDP-γ(2) MSH increased U(N) (a) V and UV by two- to threefold in rats fed the normal salt diet and by six- to sevenfold in rats fed the HS diet. Furthermore, NDP-γ(2) MSH induced a 3.5-fold increase in GFR only in rats fed the HS diet. These renal effects of NDP-γ(2) MSH were not abolished by prior renal denervation. Rats fed the HS diet also exhibited a 4.5-fold increase in MC(3) receptor expression in IMCD epithelial cells. Intrarenal infusion of NDP-γ(2) MSH induced the natriuretic but not the cardiovascular effects exhibited by γ(2) MSH. The renal activities may be attributed to a direct binding of NDP-γ(2) MSH to MC(3) receptors expressed in IMCD cells, leading to a potent natriuretic effect that is independent of renal innervation.
Study Information
pubmed
2013
2013-01-01T00:00:00.000Z
10.1111/1440-1681.12025
2
18